BridgeMD
New treatment option for Respiratory Distress Syndrome (Neonatal)
Official title How Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants
ClinicalTrials.gov ID: NCT07674953
What this study is testing
- What it's testing
- With this study, it is expected to learn more about preterm babies on breathing support with nasal continuous positive airway pressure (nCPAP). To gain more information on how much oxygen is actually delivered to the baby from the nCPAP machine.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Gestational age at birth must be less than 35 weeks of completed gestation as documented in the subject's initial history and physical
- The infant must be stable while receiving nasal CPAP at any pressure level at the time of study
- The infant must be receiving 22-40% at the time of the study
You likely can't join if
- Oxygen requirements greater than 40% at time of enrollment
- currently receiving invasive ventilation or not requiring ventilatory support
- Major congenital anomalies of the heart and/or lungs
The study team makes the final eligibility decision.
Where it's taking place
- Little Rock, Arkansas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Little Rock, Arkansas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.